Differences between revisions 19 and 21 (spanning 2 versions)
Revision 19 as of 2025-03-31 02:07:47
Size: 3056
Comment:
Revision 21 as of 2025-03-31 02:10:32
Size: 3164
Comment:
Deletions are marked like this. Additions are marked like this.
Line 11: Line 11:
 .p27 2007 roses, reduced smell [[ https://en.wikipedia.org/wiki/Hyposmia | Hyposmia ]], no smell [[ https://en.wikipedia.org/wiki/Anosmia | anosmia ]] hallucinatory smell  https://en.wikipedia.org/wiki/Phantosmia | phantosmias ]]  .p27 2007 roses, reduced smell [[ https://en.wikipedia.org/wiki/Hyposmia | Hyposmia ]], no smell [[ https://en.wikipedia.org/wiki/Anosmia | anosmia ]], hallucinatory smell: [[ https://en.wikipedia.org/wiki/Phantosmia | phantosmias ]], distorted smell: [[ https://en.wikipedia.org/wiki/Dysosmia | https://en.wikipedia.org/wiki/Dysosmia ]]

wiki.keithl.com/DanielGibbs

A Tattoo on my Brain

A Neurologist's Personal Battle against Alzheimer's Disease

Daniel Gibbs with Teresa H. Barker

Cedar Mill Library 616.8311 GIBBS

Also see Dispatches from the land of Alzheimer's 2024

No mention of (causal) pathogens, bacteria, viruses, herpes. "On

Cholesterol is mentioned on page 47-48:

"It's not as if the APOE gene is designed for destructive purposes: it's not. The APOE gene is the DNA blueprint for a specific lipoprotein, a protein that is involved in the transport of certain lipids in the blood. It comes in three variants, or alleles: APOE-2, APOE-3, and APOE-4. For reasons that are still not entirely clear, this gene for a protein involved in cholesterol transport also affects risk for acquiring Alzheimer's disease. It seems there is an effect on the proteinAPOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures beta-amyloid in the brain, but the mechanism of APOE-4 risk is probably more complicated. We just don't know yet what it is."

DanielGibbs (last edited 2025-03-31 03:50:56 by KeithLofstrom)